Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Cascini

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
The non tumour uptake of (111)In-octreotide creates new clinical indications in benign diseases, but also in oncologyG L Cascini, V Cuccurullo, L Mansi
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 11, 2013
Structural, pathophysiological and clinical aspects of diagnostic imaging in breast recurrence: the breast after treatmentV Cuccurullo, G L Cascini, L Mansi
Prostate Cancer and Prostatic Diseases|January 9, 2008
Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?C Greco, G L Cascini, O Tamburrini
Minerva Endocrinologica|December 26, 2001
[Immunological imaging using tagged octreotide]G L Cascini, V Cuccurullo, P F Rambaldi, et al.
Minerva Endocrinologica|December 26, 2001
[Role of somatostatin analogs in the treatment of neuroendocrine tumours]V Cuccurullo, G L Cascini, P F Rambaldi, et al.
Minerva Endocrinologica|April 5, 2011
Less frequent requests for In-111 pentreotide and its brothers of endocrinological interestV Cuccurullo, G L Cascini, O Tamburrini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 3, 1999
Receptor imaging with 111In-pentreotide and 123I-methoxybenzamide, and inhibition tests with octreotide and bromocriptine of mixed growth hormone/prolactin-secreting pituitary tumorsN Panza, P F Rambaldi, C Battista, et al.
Minerva Endocrinologica|December 14, 2012
Questions and answers: what can be said by diagnostic imaging in neuroendocrine tumors?V Cuccurullo, A Faggiano, M Scialpi, et al.
Journal of Surgical Oncology|February 17, 2006
Role of dynamic sentinel node biopsy in penile cancer: our experienceS Perdonà, R Autorino, L Gallo, et al.
Tumori|August 9, 2003
[Early evaluation using PET-FDG of the efficiency of neoadjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum]P Delrio, S Lastoria, A Avallone, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
The non tumour uptake of (111)In-octreotide creates new clinical indications in benign diseases, but also in oncologyG L Cascini, V Cuccurullo, L Mansi
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 11, 2013
Structural, pathophysiological and clinical aspects of diagnostic imaging in breast recurrence: the breast after treatmentV Cuccurullo, G L Cascini, L Mansi
Prostate Cancer and Prostatic Diseases|January 9, 2008
Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?C Greco, G L Cascini, O Tamburrini
Minerva Endocrinologica|December 26, 2001
[Immunological imaging using tagged octreotide]G L Cascini, V Cuccurullo, P F Rambaldi, et al.
Minerva Endocrinologica|December 26, 2001
[Role of somatostatin analogs in the treatment of neuroendocrine tumours]V Cuccurullo, G L Cascini, P F Rambaldi, et al.
Minerva Endocrinologica|April 5, 2011
Less frequent requests for In-111 pentreotide and its brothers of endocrinological interestV Cuccurullo, G L Cascini, O Tamburrini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 3, 1999
Receptor imaging with 111In-pentreotide and 123I-methoxybenzamide, and inhibition tests with octreotide and bromocriptine of mixed growth hormone/prolactin-secreting pituitary tumorsN Panza, P F Rambaldi, C Battista, et al.
Minerva Endocrinologica|December 14, 2012
Questions and answers: what can be said by diagnostic imaging in neuroendocrine tumors?V Cuccurullo, A Faggiano, M Scialpi, et al.
Journal of Surgical Oncology|February 17, 2006
Role of dynamic sentinel node biopsy in penile cancer: our experienceS Perdonà, R Autorino, L Gallo, et al.
Tumori|August 9, 2003
[Early evaluation using PET-FDG of the efficiency of neoadjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum]P Delrio, S Lastoria, A Avallone, et al.
Pageof 1